ARID1A and colorectal carcinoma: Reintroduction of wild-type ARID1A in ARID1A−/− CRC cells significantly prevented the induction of synthetic lethality in the cells, demonstrating that AURKA inhibitor-induced synthetic lethality is dependent on the ARID1A status.